Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy.
Mohamed Mohamed K, Álvarez-Hernández MP, Jiménez García C, Guevara-Hoyer K, Freites D, Martínez Prada C, Pérez-Sancristóbal I, Fernández Gutiérrez B, Mato Chaín G, Rodero M, Rodríguez de la Peña A, Mulero T, Bravo C, Toledano E, Culebras López E, Mediero Valeros B, Pérez Segura P, Sánchez-Ramón S, Candelas Rodríguez G. Mohamed Mohamed K, et al. Among authors: perez sancristobal i, perez segura p. Biomedicines. 2023 Aug 29;11(9):2418. doi: 10.3390/biomedicines11092418. Biomedicines. 2023. PMID: 37760858 Free PMC article.
Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients.
Benitez Fuentes JD, Mohamed Mohamed K, de Luna Aguilar A, Jiménez García C, Guevara-Hoyer K, Fernandez-Arquero M, Rodríguez de la Peña MA, Garciía Bravo L, Jiménez Ortega AF, Flores Navarro P, Bartolome Arcilla J, Alonso Arenilla B, Baos Muñoz E, Delgado-Iribarren García-Campero A, Montealegre Sanz M, Sanchez-Ramon S, Perez Segura P. Benitez Fuentes JD, et al. Among authors: perez segura p. Front Oncol. 2022 Dec 20;12:975980. doi: 10.3389/fonc.2022.975980. eCollection 2022. Front Oncol. 2022. PMID: 36605446 Free PMC article.
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors.
Mohamed KM, Guevara-Hoyer K, García CJ, Bravo LG, Jiménez-Huete A, de la Peña AR, Valeros BM, Velázquez CC, López EC, Cabello N, Estrada V, Corbí ÁL, Fernández-Arquero M, Ocaña A, Delgado-Iribarren A, Martínez-Novillo M, Bolaños E, Anguita E, Peña A, Benavente C, Benítez Fuentes JD, Pérez Segura P, Sánchez-Ramón S. Mohamed KM, et al. Among authors: perez segura p. Biomedicines. 2023 Mar 28;11(4):1042. doi: 10.3390/biomedicines11041042. Biomedicines. 2023. PMID: 37189660 Free PMC article.
Exploring gastric cancer genetics: A turning point in common variable immunodeficiency.
Sánchez-Ramón S, Fuentes-Antrás J, Rider NL, Pérez-Segura P, de la Fuente-Muñoz E, Fernández-Arquero M, Neves E, Pérez de Diego R, Ocaña A, Guevara-Hoyer K. Sánchez-Ramón S, et al. Among authors: perez segura p, perez de diego r. J Allergy Clin Immunol Glob. 2023 Dec 23;3(2):100203. doi: 10.1016/j.jacig.2023.100203. eCollection 2024 May. J Allergy Clin Immunol Glob. 2023. PMID: 38283086 Free PMC article.
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain.
Benitez Fuentes JD, de Luna Aguilar A, Jimenez Ortega AF, Flores Navarro P, Bartolomé Arcilla J, Baos Muñoz E, Delgado-Iribarren García-Campero A, Gil Useros S, Martinez Capella I, Llorente Sanz L, Torrego Ellacuría M, Pérez Segura P. Benitez Fuentes JD, et al. Among authors: perez segura p. F1000Res. 2022 Apr 19;11:434. doi: 10.12688/f1000research.110268.2. eCollection 2022. F1000Res. 2022. PMID: 36636471 Free PMC article.
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel FJ, Barreiro P, Salavert M, Cabello A, Fernández-Ruiz M, Pérez-Segura P, San Román J, Berenguer J, Córdoba R, Delgado R, España PP, Gómez-Centurión IA, González Del Castillo JM, Heili SB, Martínez-Peromingo FJ, Menéndez R, Moreno S, Pablos JL, Pasquau J, Piñana JL, On Behalf Of The Modus Investigators Adenda. Candel FJ, et al. Among authors: perez segura p. Viruses. 2023 Jun 27;15(7):1449. doi: 10.3390/v15071449. Viruses. 2023. PMID: 37515137 Free PMC article. Review.
Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer.
Cabezas-Camarero S, Iglesias-Moreno MC, Cerezo Druet E, Sotelo MJ, Merino-Menéndez S, Cabrera-Martín MN, Plaza-Hernández JC, Pérez-Segura P. Cabezas-Camarero S, et al. Among authors: perez segura p. Anticancer Drugs. 2023 Jun 1;34(5):695-698. doi: 10.1097/CAD.0000000000001422. Epub 2022 Nov 17. Anticancer Drugs. 2023. PMID: 36730545
Response to Yilmaz et al.
Cabezas-Camarero S, Iglesias-Moreno MC, Cerezo Druet E, Sotelo MJ, Merino-Menéndez S, Cabrera-Martín MN, Plaza-Hernández JC, Pérez-Segura P. Cabezas-Camarero S, et al. Among authors: perez segura p. Anticancer Drugs. 2024 Jun 1;35(5):481-482. doi: 10.1097/CAD.0000000000001585. Epub 2024 Apr 3. Anticancer Drugs. 2024. PMID: 38567818 No abstract available.
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck.
Cabezas-Camarero S, García-Barberán V, Benítez-Fuentes JD, Sotelo MJ, Plaza JC, Encinas-Bascones A, De-la-Sen Ó, Falahat F, Gimeno-Hernández J, Gómez-Serrano M, Puebla-Díaz F, De-Pedro-Marina M, Iglesias-Moreno M, Pérez-Segura P. Cabezas-Camarero S, et al. Among authors: perez segura p. Cancers (Basel). 2023 Apr 24;15(9):2431. doi: 10.3390/cancers15092431. Cancers (Basel). 2023. PMID: 37173898 Free PMC article.
182 results